A new trading day began on Monday, with Bristol-Myers Squibb Co (NYSE: BMY) stock price up 2.08% from the previous day of trading, before settling in for the closing price of $54.32. BMY’s price has ranged from $39.35 to $56.20 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
During the last 5-year period, the sales growth of Healthcare Sector giant was 16.92%. Meanwhile, its annual earnings per share averaged -88.71%. With a float of $2.03 billion, this company’s outstanding shares have now reached $2.03 billion.
Let’s determine the extent of company efficiency that accounts for 34100 employees. In terms of profitability, gross margin is 70.41%, operating margin of 26.81%, and the pretax margin is -14.5%.
Bristol-Myers Squibb Co (BMY) Insider Activity
As we move forward, let’s examine how large-scale investors are investing in this stock of the Drug Manufacturers – General Industry. The insider ownership of Bristol-Myers Squibb Co is 0.08%, while institutional ownership is 77.19%. The most recent insider transaction that took place on Nov 04 ’24, was worth 38,930. Before that another transaction happened on Dec 05 ’23, when Company’s Chief Executive Officer bought 2,000 for $49.78, making the entire transaction worth $99,560. This insider now owns 82,672 shares in total.
Bristol-Myers Squibb Co (BMY) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around -88.71% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -3.66% during the next five years compared to 5.14% growth over the previous five years of trading.
Bristol-Myers Squibb Co (NYSE: BMY) Trading Performance Indicators
Here are Bristol-Myers Squibb Co’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 1.09. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 2.31. Likewise, its price to free cash flow for the trailing twelve months is 7.94.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -3.60, a number that is poised to hit 1.48 in the next quarter and is forecasted to reach 7.04 in one year’s time.
Technical Analysis of Bristol-Myers Squibb Co (BMY)
Looking closely at Bristol-Myers Squibb Co (NYSE: BMY), its last 5-days average volume was 12.09 million, which is a drop from its year-to-date volume of 14.47 million. As of the previous 9 days, the stock’s Stochastic %D was 76.77%. Additionally, its Average True Range was 1.28.
During the past 100 days, Bristol-Myers Squibb Co’s (BMY) raw stochastic average was set at 95.55%, which indicates a significant increase from 82.92% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 31.59% in the past 14 days, which was higher than the 30.30% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $51.37, while its 200-day Moving Average is $47.97. However, in the short run, Bristol-Myers Squibb Co’s stock first resistance to watch stands at $56.04. Second resistance stands at $56.63. The third major resistance level sits at $57.49. If the price goes on to break the first support level at $54.59, it is likely to go to the next support level at $53.73. Should the price break the second support level, the third support level stands at $53.14.
Bristol-Myers Squibb Co (NYSE: BMY) Key Stats
With a market capitalization of 109.54 billion, the company has a total of 2,027,395K Shares Outstanding. Currently, annual sales are 45,006 M while annual income is 8,025 M. The company’s previous quarter sales were 12,201 M while its latest quarter income was 1,680 M.
